Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CD86 Stable Cell Line

    [CAT#: S01YF-1023-PY223]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    CD Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    CD
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;RPMI-8226;MM1.S
    Target Classification
    CD Cell Lines
    Target Research Area
    Infectious Research
    Related Diseases
    Plague; Cowpox
    Gene ID
    Human:942
    UniProt ID
    Human:P42081

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    CD86 is a protein that plays a role in various applications. In a study comparing the effects of lipid emulsions in human peripheral blood mononuclear cells (PBMCs), it was found that incubation with n-3 PUFA-rich lipid emulsion (Omegaven) led to an increase in CD86 expression in CD14+ monocytes. This increase in CD86 expression was associated with immunological synapse formation and an increase in IL-10 production, leading to a reduction in pro-inflammatory cytokines and an increase in T regulatory cells. Another study showed that targeting Tau-tubulin kinase 1 (TTBK1) with antisense oligonucleotides (ASOs) reduced the expression of phosphorylated tau in the hippocampus of PS19 tauopathy mice. CD86 was also found to be a potential biomarker of carotid atherosclerosis, with higher expression of CD86 associated with worse prognosis. Additionally, Toll-like receptor (TLR) agonists were found to affect the immunogenicity of MVA-SARS-2-S vaccine, with TLR3 agonist enhancing cellular immune responses. These findings suggest that CD86 and its modulation through various mechanisms have implications in inflammation, neurodegenerative diseases, atherosclerosis, and vaccine development.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CD86 Stable Cell Line (S01YF-1023-PY223). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Morgan Garcia (Verified Customer)

    What is the role of CD86 in immune cell interactions? Feb 06 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CD86 is crucial for the activation and regulation of T cells by binding to CD28 and CTLA-4 on T cells, playing a significant role in immune responses. Feb 06 2020

    chat Peyton Jones (Verified Customer)

    How does CD86 expression affect cancer immunotherapy? Aug 11 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CD86 expression on tumor-associated macrophages can predict prognosis in cancers like intrahepatic cholangiocarcinoma, indicating its potential as a biomarker for immunotherapy. Aug 11 2021

    Published Data

    Fig.1 Silencing of CD86 promotes in myeloma cell death

    Lentivral particles containing either individual shRNAs or an empty vector (pLKO.1) were used to infect myeloma cell lines. The infection was observed for four days using annexin V-fluorescein isothiocyanate staining to measure cell death. The pLKO.1controls (left) were used to compare the data for each time point. Measurement of mRNA quantification using qRT-PCR, with levels of CD28 or CD86 compared to vector-controls (middle). On day four after infection, representative histograms display the surface levels of CD28 or CD86. Isotype controls are shown as thin gray histograms on the left (right).

    Ref: Gavile, Catherine M., et al. "CD86 regulates myeloma cell survival." Blood advances 1.25 (2017): 2307-2319.

    Pubmed: 29296880

    DOI: 10.1182/bloodadvances.2017011601

    Research Highlights

    Liu, Zhenfeng. et al. "Pachymic Acid Prevents Hemorrhagic Shock-Induced Cardiac Injury by Suppressing M1 Macrophage Polarization and NF-[Formula: see text]B Signaling Pathway." The American journal of Chinese medicine, 2023.
    Hemorrhagic shock is a common cause of mortality among trauma patients. The resulting inflammation may cause damage to the heart. A promising treatment for this condition is pachymic acid, a triterpenoid derived from Poria cocos. Studies have demonstrated its anti-inflammatory properties and potential for reducing cardiac damage.
    Liu, Zhenfeng. et al. "Pachymic Acid Prevents Hemorrhagic Shock-Induced Cardiac Injury by Suppressing M1 Macrophage Polarization and NF-[Formula: see text]B Signaling Pathway." The American journal of Chinese medicine, 2023.
    Pubmed: 37865871   DOI: 10.1142/S0192415X23500921

    Zhao, Man. et al. "Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis." Medicine, 2023.
    Carotid atherosclerosis (AS) is a common disease that affects the carotid artery and can lead to severe conditions such as transient ischemic attack and stroke. The relationship between pleckstrin (PLEK) and lymphocyte antigen 86 (LY86) and carotid AS is still not fully understood. To investigate this, the authors downloaded datasets GSE43292 and GSE125771 from the gene expression omnibus database and conducted differential gene expression analysis, weighted gene co-expression network analysis, protein-protein interaction network analysis, and functional enrichment analysis. They also identified 10 core genes (TYROBP, FCER1G, PLEK, LY86, IL10RA, ITGB2, LCP2, FCGR2B, CD86, CCR1) and found that PLEK and LY86 were highly expressed in carotid AS samples compared to normal samples. Furthermore, comparative toxicogenomics database analysis revealed 5 genes associated with pneumonia, inflammation, necrosis, and drug allergy. In conclusion, the study suggests that PLEK and LY86 play a significant role in carotid AS and may have prognostic value.
    Zhao, Man. et al. "Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis." Medicine, 2023.
    Pubmed: 37861500   DOI: 10.1097/MD.0000000000034445

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare